Thompson Siegel & Walmsley’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.79M	Buy	12,676 +769	+6%	+$589K	0.17%	133
2025 Q4	$9.19M	Sell	11,907 -175	-1%	-$119K	0.15%	148
2025 Q3	$6.79M	Buy	12,082 +996	+9%	+$563K	0.11%	183
2025 Q2	$5.82M	Buy	11,086 +1,010	+10%	+$564K	0.1%	196
2025 Q1	$6.39M	Buy	10,076 +2,424	+32%	+$1.67M	0.11%	160
2024 Q4	$5.45M	Buy	7,652 +162	+2%	+$136K	0.09%	195
2024 Q3	$7.87M	Sell	7,490 -1,124	-13%	-$1.25M	0.12%	155
2024 Q2	$9.05M	Sell	8,614 -116	-1%	-$112K	0.15%	138
2024 Q1	$8.4M	Sell	8,730 -2,431	-22%	-$2.31M	0.13%	151
2023 Q4	$9.8M	Sell	11,161 -612	-5%	-$504K	0.16%	131
2023 Q3	$9.69M	Buy	11,773 +337	+3%	+$265K	0.16%	130
2023 Q2	$8.22M	Buy	11,436 +21	+0.2%	+$16.2K	0.13%	158
2023 Q1	$9.38M	Buy	11,415 +423	+4%	+$319K	0.15%	139
2022 Q4	$7.93M	Sell	10,992 -411	-4%	-$303K	0.13%	157
2022 Q3	$7.86M	Sell	11,403 -96	-0.8%	-$60.4K	0.14%	158
2022 Q2	$6.8M	Buy	11,499 +35	+0.3%	+$22.8K	0.11%	167
2022 Q1	$8.01M	Buy	11,464 +71	+0.6%	+$44.9K	0.11%	174
2021 Q4	$7.2M	Buy	11,393 +313	+3%	+$192K	0.1%	179
2021 Q3	$6.71M	Buy	11,080 +235	+2%	+$146K	0.1%	179
2021 Q2	$6.06M	Buy	+10,845	New	+$5.49M	0.08%	184
2018 Q2	–	Sell	-41	Closed	-$14K	–	820
2018 Q1	$14K	Hold	41	–	–	﹤0.01%	658
2017 Q4	$15K	Hold	41	–	–	﹤0.01%	677
2017 Q3	$18K	Hold	41	–	–	﹤0.01%	658
2017 Q2	$20K	Hold	41	–	–	﹤0.01%	651
2017 Q1	$16K	Sell	41 -6	-13%	-$2.22K	﹤0.01%	662
2016 Q4	$17K	Hold	47	–	–	﹤0.01%	607
2016 Q3	$19K	Hold	47	–	–	﹤0.01%	588
2016 Q2	$16K	Buy	+47	New	+$18.1K	﹤0.01%	588